Citation:
Foley DA, Phuong LK. RSV: an update on prevention and management. Aust Prescr. 2025;48(2):34-9.
Keywords:
RSV vaccines; nirsevimab; respiratory syncytial virus; respiratory tract infections
Abstract:
Respiratory syncytial virus (RSV) is a common cause of respiratory tract infections in infants and young children, and adults over 60 years of age. Infants born prematurely, adults aged over 75 years, individuals with medical conditions such as chronic cardiac or respiratory disease, or obesity, and Aboriginal and Torres Strait Islander people are at increased risk of severe RSV disease.